Identification of sentinel lymph node in breast cancer: Experience from the Institut Curie;Individualisation du ganglion sentinelle en cas de cancer du sein: Experience de l'Institut Curie

Bulletin du Cancer

Volumn 86, Issue 6, 1999, Pages 580-584

  Nos, Claude ^a   Bourgeois, Didier ^a   Freneaux, Paul ^a   Zafrani, Brigitte ^a   Salmon, Rémy J ^b   Clough, Krishna B ^a  

^a INSTITUT CURIE   (France)

^b NONE

Author keywords

Axillary dissection; Breast carcinoma; Sentinel node

Indexed keywords

DISULFINE BLUE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; DIAGNOSTIC ACCURACY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COLORING AGENTS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; ROSANILINE DYES;

EID: 0032866447     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. 1. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR. Sentinel lymph node biopsy for breast cancer. Not yet the standard of care. N Engl J Med 1998 ; 339 : 990-5.
2. 2. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993 ; 2 : 335-40.
3. 3. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic maping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994 ; 220 : 391-401.
4. 4. Salmon RJ, Fried D. Mise en évidence du ganglion sentinelle dans le curage axillaire pour cancer du sein. Press Med 1998 ; 27 : 509-12.
5. 5. Bobin JY, Zinzindohoue C, Roy P. Étude du ganglion sentinelle : à propos de 100 cas. Bull Cancer 1998 ; 85 : 418.
6. 6. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997 ; 15 : 2345-50.
7. 7. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Scient Am 1997 ; 3 : 336-40.
8. 8. Rodier JF, Janser JC. Surgical technical details improving sentinel node identification in breast cancer. Oncology Rep 1997 ; 4 : 281-3.
9. 9. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995 ; 222 : 394-401.
10. 10. Krag DN, Weaver DL, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998 ; 339 : 941-6.
11. 11. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997 ; 23 : 495-502.
12. 12. Snider H, Dowlatshahi K, Fan M, Bridger WM, Rayudu G, Oleske D. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998 ; 176 : 305-10.
13. 13. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997 ; 349 : 1864-7.
14. 14. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997 ; 369 : 1668-9.
15. 15. Paganelli G, De Cicco C, Cremonesi M, Prisco G, Calza P, Luini A, et al. Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 1998 ; 42: 49-53.
16. 16. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans FI, Boom R. Impact of lymphoscintigraphy on sentinel node identification with technetium 99m colloidal albumin in breast cancer. J Nucl Med 1997 ; 38 : 366-8.
17. 17. Veronesi U, Zurrida S, Galimberti V. Consequences of sentinel node in clinical decision making in breast cancer and prospect for future studies. Eur J Surg Oncol 1998 ; 2 : 93-5.
18. 18. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998 ; 227 : 645-53.
19. 19. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996 ; 276 : 1818-22.
20. 20. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997 ; 226 : 271-8.
21. 21. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin R, Contesso G. Importance of tumors cells in axillary node sinus margins ("clandestine" metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 1988 ; 27 : 483-7.
22. 22. International (Ludwig) Breast Cancer Study Group. Pronostic importance of occult axillary lymph node metastases from breast cancer. Lancet 1990 ; 335 : 1565-8.
23. 23. Hainswoorth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA. Detection and significance of occult metastases in "node-negative" breast cancer. Br J Surg 1993 ; 80 : 459-63.
24. 24. de Mascarel I, Bonichon F, Coincre JM, Trojani M. Pronostic significance of breast cancer axillary micrometastases assessed with two special techniques : reevaluation with longer follow-up. Br J Cancer 1992 ; 66 : 523-7.
25. 25. Nasser IA, Lee AKC, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993 ; 24 : 950-7.
26. 26. Jansen L, Nieweg OE, Valdes Olmos RA, Rutgers EJ, Peterse JL, de Vries J. Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy. Eur J Surg Oncol 1998 ; 24 : 445-6.
27. 27. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer. Cancer 1995 ; 76: 1491-512.
28. 28. Anonyme. Recommandations européennes pour l'assurance de qualité dans le cadre du dépistage mammographique du cancer du sein. Rapport des anatomopathologistes du groupe de travail « Dépistage du cancer du sein » de l'Union européenne. Ann Pathol 1996 ; 16 : 315-33.